{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:54Z","timestamp":1793442714145,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL160540"],"award-info":[{"award-number":["R01 HL160540"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115435","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:33:04Z","timestamp":1791318784000},"page":"115435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Lung surfactants as a component of lipid nanoparticles for pulmonary mRNA delivery"],"prefix":"10.1016","volume":"399","author":[{"given":"Sarah S.","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen E.","family":"Tabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Poore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115435_bb0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: the COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"52","key":"10.1016\/j.jconrel.2026.115435_bb0015","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"44","key":"10.1016\/j.jconrel.2026.115435_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310395","article-title":"Spleen SORT LNP generated in situ CAR T cells extend survival in a mouse model of lymphoreplete B cell lymphoma","volume":"62","author":"\u00c1lvarez-Benedicto","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.70125","article-title":"Tissue-specific gene delivery approaches","volume":"11","author":"Nasr","year":"2026","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115435_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.07.058","article-title":"The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles","volume":"361","author":"Dilliard","year":"2023","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0040","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115435_bb0045","doi-asserted-by":"crossref","first-page":"103479","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"Iscience"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115435_bb0050","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115435_bb0055","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.actbio.2025.08.032","article-title":"Sulfonium lipid nanoparticles for intranasal mRNA delivery to lung epithelial and immune cells","volume":"205","author":"Men","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115435_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-026-01615-9","article-title":"\u2018Tripod-like\u2019 lung-targeting (LuT) lipids for highly efficient and selective LNPs for gene delivery and editing","author":"Tian","year":"2026","journal-title":"Nat Biomed Eng."},{"key":"10.1016\/j.jconrel.2026.115435_bb0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2022.10.020","article-title":"Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment","volume":"352","author":"Zhang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115435_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107383","article-title":"Impact of formulation and process parameters on the stability and bioactivity of RNA-loaded lipid nanoparticles during nebulization","volume":"216","author":"Wiebe","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115435_bb0075","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115435_bb0080","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115435_bb0085","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115435_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10580","article-title":"Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles","volume":"8","author":"Lewis","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115435_bb0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/acsmacrolett.3c00183","article-title":"Increase nebulization stability of lipid nanoparticles by integrating a DNA supramolecular hydrogel","volume":"12","author":"Wei","year":"2023","journal-title":"ACS Macro Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115435_bb0100","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115435_bb0105","doi-asserted-by":"crossref","DOI":"10.26599\/NR.2025.94907874","article-title":"Inhalable mRNA therapeutics for pulmonary diseases: challenges in delivery and advances in carrier design","volume":"18","author":"Liang","year":"2025","journal-title":"Nano Res."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115435_bb0110","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1039\/D4NA01034E","article-title":"RNA lipid nanoparticles stabilized during nebulization through excipient selection","volume":"7","author":"Slaughter","year":"2025","journal-title":"Nanoscale Adv."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102375","article-title":"Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia","volume":"35","author":"Soto","year":"2024","journal-title":"Mol. Ther. Nucleic Acids."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115435_bb0120","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1021\/acsptsci.4c00419","article-title":"PEGylation-dependent cell uptake of lipid nanoparticles revealed by spatiotemporal correlation spectroscopy","volume":"7","author":"Digiacomo","year":"2024","journal-title":"ACS Pharmacol Transl Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115435_bb0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13346-013-0176-5","article-title":"Questioning the use of PEGylation for drug delivery","volume":"3","author":"Verhoef","year":"2013","journal-title":"Drug Deliv. Transl Res."},{"key":"10.1016\/j.jconrel.2026.115435_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.actbio.2021.11.034","article-title":"Physicochemical properties of nanoparticles affecting their fate and the physiological function of pulmonary surfactants","volume":"140","author":"Liu","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115435_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.actbio.2022.05.038","article-title":"The influence of a biomimetic pulmonary surfactant modification on the in vivo fate of nanoparticles in the lung","volume":"147","author":"Liu","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115435_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213430","article-title":"Development and characterization of lung surfactant-coated polymer nanoparticles for pulmonary drug delivery","volume":"150","author":"Gonsalves","year":"2023","journal-title":"Biomater. Adv."},{"issue":"22","key":"10.1016\/j.jconrel.2026.115435_bb0150","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1021\/acs.nanolett.3c03547","article-title":"Inhalable gene therapy and the lung surfactant problem","volume":"23","author":"Kassab","year":"2023","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115435_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040775","article-title":"The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. Prow TW, editor","volume":"7","author":"Ruge","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115435_bb0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejpb.2022.01.009","article-title":"Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung","volume":"172","author":"Zhao","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115435_bb0165","doi-asserted-by":"crossref","first-page":"19436","DOI":"10.1038\/s41598-020-76332-7","article-title":"Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells","volume":"10","author":"Radiom","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115435_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejpb.2015.02.014","article-title":"Barrier or carrier? Pulmonary surfactant and drug delivery","volume":"95","author":"Hidalgo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.115435_bb0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/pr.2016.203","article-title":"Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future","volume":"81","author":"Sardesai","year":"2017","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230229","article-title":"In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits. Simeoni U, editor","volume":"15","author":"Guo","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115435_bb0185","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/BF02534515","article-title":"Lung surfactant phospholipids in different animal species","volume":"19","author":"Shelley","year":"1984","journal-title":"Lipids"},{"key":"10.1016\/j.jconrel.2026.115435_bb0190","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.actbio.2018.08.012","article-title":"Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy","volume":"78","author":"Merckx","year":"2018","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115435_bb0195","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.1021\/acsnano.0c04489","article-title":"Surfactant protein B promotes cytosolic SiRNA delivery by adopting a virus-like mechanism of action","volume":"15","author":"Guagliardo","year":"2021","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115435_bb0200","article-title":"Pulmonary surfactant protein SP-C regulates lipid vesicle uptake by alveolar type II cells and macrophages: role of lipids, palmitoylation, and environment","volume":"1870","author":"Mor\u00e1n-Lalangui","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jconrel.2026.115435_bb0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.addr.2015.03.017","article-title":"Particle tracking in drug and gene delivery research: state-of-the-art applications and methods","volume":"91","author":"Schuster","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115435_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0005-2736(00)00256-X","article-title":"Role of pulmonary surfactant components in surface film formation and dynamics","volume":"1467","author":"Veldhuizen","year":"2000","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115435_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1095-6433(01)00308-7","article-title":"Surfactant-associated proteins: functions and structural variation","volume":"129","author":"Haagsman","year":"2001","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"issue":"28","key":"10.1016\/j.jconrel.2026.115435_bb0220","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1021\/bi00242a015","article-title":"Surfactant protein B: disulfide bridges, structural properties and kringle similarities","volume":"30","author":"Johansson","year":"1991","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0225","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/0929867328666210825110421","article-title":"Pulmonary surfactant: a unique biomaterial with life-saving therapeutic applications","volume":"29","author":"Pioselli","year":"2022","journal-title":"CMC"},{"key":"10.1016\/j.jconrel.2026.115435_bb0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","article-title":"Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins","volume":"291","author":"Guagliardo","year":"2018","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0235","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0006-3495(03)74663-3","article-title":"Interaction of pulmonary surfactant protein SP-A with DPPC\/egg-PG bilayers","volume":"85","author":"Morrow","year":"2003","journal-title":"Biophys. J."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115435_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276787","article-title":"Emulation of the structure of the Saposin protein fold by a lung surfactant peptide construct of surfactant protein B","volume":"17","author":"Waring","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115435_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2022.100101","article-title":"Lung surfactant as a biophysical assay for inhalation toxicology","volume":"4","author":"Liu","year":"2023","journal-title":"Curr. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0250","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1529\/biophysj.107.106765","article-title":"Solubility versus electrostatics: what determines lipid\/protein interaction in lung surfactant","volume":"93","author":"Seifert","year":"2007","journal-title":"Biophys. J."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115435_bb0255","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/S0006-3495(01)76198-X","article-title":"Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability","volume":"80","author":"Ding","year":"2001","journal-title":"Biophys. J."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.115435_bb0260","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0005-2736(00)00199-1","article-title":"Pulmonary surfactant protein B: a structural model and a functional analogue","volume":"1466","author":"Zaltash","year":"2000","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"2\u20133","key":"10.1016\/j.jconrel.2026.115435_bb0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00249-012-0858-9","article-title":"Structure\u2013function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins","volume":"42","author":"Olmeda","year":"2013","journal-title":"Eur. Biophys. J."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115435_bb0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12195-022-00727-x","article-title":"High-density branched PEGylation for nanoparticle drug delivery","volume":"15","author":"Cahn","year":"2022","journal-title":"Cell. Mol. Bioeng."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115435_bb0275","doi-asserted-by":"crossref","DOI":"10.1063\/5.0091025","article-title":"Machine learning-informed predictions of nanoparticle mobility and fate in the mucus barrier","volume":"6","author":"Kaler","year":"2022","journal-title":"APL Bioeng."},{"issue":"18","key":"10.1016\/j.jconrel.2026.115435_bb0280","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88198","article-title":"Microstructural alterations of sputum in cystic fibrosis lung disease","volume":"1","author":"Duncan","year":"2016","journal-title":"JCI Insight"},{"issue":"43","key":"10.1016\/j.jconrel.2026.115435_bb0285","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.1021\/acs.langmuir.0c02410","article-title":"Mucin biopolymers and their barrier function at airway surfaces","volume":"36","author":"Song","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115435_bb0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.addr.2017.11.001","article-title":"Mucus models to evaluate the diffusion of drugs and particles","volume":"124","author":"Lock","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0295","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601556","article-title":"Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation","volume":"3","author":"Schneider","year":"2017","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115435_bb0300","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/17425247.2021.1854222","article-title":"Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung","volume":"18","author":"Chen","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"28","key":"10.1016\/j.jconrel.2026.115435_bb0305","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1073\/pnas.1502281112","article-title":"Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy","volume":"112","author":"Mastorakos","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115435_bb0310","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.omtm.2018.03.006","article-title":"An adeno-associated viral vector capable of penetrating the mucus barrier to inhaled gene therapy","volume":"9","author":"Duncan","year":"2018","journal-title":"Mol. Ther. Meth. Clin. Develop."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115435_bb0315","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11095-025-03890-8","article-title":"Mechanism of pH-sensitive amphiphilic endosomal escape of ionizable lipid nanoparticles for cytosolic nucleic acid delivery","volume":"42","author":"Lu","year":"2025","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115435_bb0320","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0325","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bpj.2012.12.041","article-title":"An anionic phospholipid enables the hydrophobic surfactant proteins to alter spontaneous curvature","volume":"104","author":"Chavarha","year":"2013","journal-title":"Biophys. J."},{"issue":"42","key":"10.1016\/j.jconrel.2026.115435_bb0330","doi-asserted-by":"crossref","first-page":"38265","DOI":"10.1021\/jacs.5c10908","article-title":"Spatial conformation of ionizable lipids regulates endosomal membrane disruption","volume":"147","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"36","key":"10.1016\/j.jconrel.2026.115435_bb0335","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1021\/acs.jpcb.3c04489","article-title":"Phosphatidylethanolamine and cholesterol promote hemifusion formation: a tug of war between membrane interfacial order and intrinsic negative curvature of lipids","volume":"127","author":"Mishra","year":"2023","journal-title":"J. Phys. Chem. B"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115435_bb0340","article-title":"Cubic phase-inducible zwitterionic phospholipids improve the functional delivery of mRNA","volume":"12","author":"Iwakawa","year":"2025","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041184","article-title":"Key design features of lipid nanoparticles and electrostatic charge-based lipid nanoparticle targeting","volume":"15","author":"Gyanani","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115435_bb0350","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR\u2013Cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115435_bb0355","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbamem.2011.12.007","article-title":"A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant","volume":"1818","author":"Keating","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0360","first-page":"L335","article-title":"Functional importance of the NH2 -terminal insertion sequence of lung surfactant protein B","volume":"298","author":"Frey","year":"2010","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0365","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/BJ20110681","article-title":"A combined action of pulmonary surfactant proteins SP-B and SP-C modulates permeability and dynamics of phospholipid membranes","volume":"438","author":"Parra","year":"2011","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115435_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.166749","article-title":"Towards the molecular mechanism of pulmonary surfactant protein SP-B: at the crossroad of membrane permeability and interfacial lipid transfer","volume":"433","author":"Mart\u00ednez-Calle","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115435_bb0375","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bpj.2012.11.014","article-title":"Hydrophobic pulmonary surfactant proteins SP-B and SP-C induce pore formation in planar lipid membranes: evidence for proteolipid pores","volume":"104","author":"Parra","year":"2013","journal-title":"Biophys. J."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115435_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2026.115435_bb0385","article-title":"The effect of particle size on drug bioavailability in various parts of the body","volume":"2","author":"Mok","year":"2024","journal-title":"Pharmaceut. Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115435_bb0390","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acscentsci.9b01139","article-title":"Size-tunable strategies for a tumor targeted drug delivery system","volume":"6","author":"Yu","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115435_bb0395","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/jamp.2009.0797","article-title":"Update on macrophage clearance of inhaled micro- and nanoparticles","volume":"23","author":"Geiser","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115435_bb0400","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jconrel.2022.05.006","article-title":"Exploring the intrinsic micro\u2212\/nanoparticle size on their in vivo fate after lung delivery","volume":"347","author":"Liu","year":"2022","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:50:10Z","timestamp":1793440210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":80,"alternative-id":["S0168365926008394"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115435","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung surfactants as a component of lipid nanoparticles for pulmonary mRNA delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115435"}}